利伐沙班在卒中高危心房颤动患者中的治疗效果等同于华法林。 - Suppr

Suppr

超能文献

Rivaroxaban equals warfarin treatment in atrial fibrillation patients at high risk of stroke.

作者信息

Aalbers J

出版信息

Cardiovasc J Afr. 2010 Nov-Dec;21(6):342-3.

PMID:21135986

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6107728/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8d4/6107728/68d58b38132d/cvja-21-342-g001.jpg

相似文献

Rivaroxaban equals warfarin treatment in atrial fibrillation patients at high risk of stroke.利伐沙班在卒中高危心房颤动患者中的治疗效果等同于华法林。

Cardiovasc J Afr. 2010 Nov-Dec;21(6):342-3.

New alternative to warfarin may help reduce stroke risk in patients with AF.华法林的新替代药物可能有助于降低房颤患者的中风风险。

JAMA. 2011 Jan 5;305(1):25-6. doi: 10.1001/jama.2010.1894.

Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation.新型口服抗凝剂用于心房颤动患者的疗效及安全性比较

Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):480-6. doi: 10.1161/CIRCOUTCOMES.112.965988. Epub 2012 Jul 10.

Oral anticoagulation in atrial fibrillation: balancing the risk of stroke with the risk of bleed.心房颤动的口服抗凝治疗：平衡卒中风险与出血风险。

Can Fam Physician. 2012 Aug;58(8):850-8.

Rivaroxaban for stroke prevention in atrial fibrillation: a critical review of the ROCKET AF trial.利伐沙班用于心房颤动的卒中预防：ROCKET AF试验的批判性综述

Expert Rev Cardiovasc Ther. 2012 Aug;10(8):965-72. doi: 10.1586/erc.12.91.

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.利伐沙班与华法林用于非瓣膜性心房颤动。

N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10.

Summaries for patients. Rivaroxaban in patients transitioned from vitamin K antagonist therapy.患者摘要。从维生素K拮抗剂治疗转换而来的患者使用利伐沙班的情况。

Ann Intern Med. 2013 Jun 18;158(12):I-28. doi: 10.7326/0003-4819-158-12-201306180-00001.

Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in Chinese patients with atrial fibrillation.利伐沙班与华法林相比对中国房颤患者预防中风和全身性栓塞的效果

Vascular. 2014 Aug;22(4):252-8. doi: 10.1177/1708538113490423. Epub 2013 Jun 18.

Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.新型口服抗凝剂（达比加群、利伐沙班、阿哌沙班）与华法林治疗心房颤动患者的疗效和安全性的荟萃分析。

Am J Cardiol. 2012 Aug 1;110(3):453-60. doi: 10.1016/j.amjcard.2012.03.049. Epub 2012 Apr 24.

Rivaroxaban versus warfarin in Japanese patients with nonvalvular atrial fibrillation in relation to the CHADS2 score: a subgroup analysis of the J-ROCKET AF trial.利伐沙班与华法林在 CHADS2 评分相关的非瓣膜性心房颤动日本患者中的比较：J-ROCKET AF 试验的亚组分析。

J Stroke Cerebrovasc Dis. 2014 Feb;23(2):379-83. doi: 10.1016/j.jstrokecerebrovasdis.2013.07.021. Epub 2013 Aug 15.

引用本文的文献

Graphical representation of network meta-analysis: an iconographic support to the complexity of multiple data comparisons.网络荟萃分析的图形表示：对多数据比较复杂性的图像支持。

Eur J Clin Pharmacol. 2019 Jan;75(1):131-132. doi: 10.1007/s00228-018-2551-0. Epub 2018 Sep 10.

Illustrating the Sense of a Network Meta-Analysis by Means of Dedicated Plots: A Way for Making It Conceptually Easier and More Immediately Understandable.通过专用图表说明网络荟萃分析的意义：一种使其在概念上更易于理解且能即刻领会的方法。

J Clin Med Res. 2018 Sep;10(9):732-735. doi: 10.14740/jocmr3536w. Epub 2018 Jul 31.

New anticoagulants - promising and failed developments.新型抗凝药物——有前景与失败的研发进展。

Br J Pharmacol. 2012 Jan;165(2):363-72. doi: 10.1111/j.1476-5381.2011.01578.x.

本文引用的文献

The RE-LY study: Randomized Evaluation of Long-term anticoagulant therapY: dabigatran vs. warfarin.

Eur Heart J. 2009 Nov;30(21):2554-5. doi: 10.1093/eurheartj/ehp384. Epub 2009 Sep 21.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验